The Pre-medical Cancer Immunotherapy Network for Canine Trials (PRECINCT) renewed for another five years

The Pre-medical Cancer Immunotherapy Network for Canine Trials (PRECINCT) renewed for another five years

Posted on: September 2022

September 2022: The Pre-medical Cancer Immunotherapy Network for Canine Trials (PRECINCT) renewed for another five years

Qi Long, PhD and Nicola Mason, B.Vet.Med, PhD received a new five year U24 grant from NIH/NCI to continue leading the Coordinating Center for the Pre-medical Cancer Immunotherapy Network for Canine Trials (PRECINCT), part of the NCI's Cancer Moonshot Initiative. More information about PRECINCT can be found by clicking the button below.